Global Medical Solutions purchases the Australian Radiopharmacy Servicing Business of Lantheus Holdings, Inc., parent company of Lantheus Medical Imaging, Inc.
The purchase includes Lantheus radiopharmacies in greater Melbourne, Victoria and in greater Adelaide, South Australia. Additionally, GMS will distribute Lantheus products within the GMS global footprint, including DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension in Australia and New Zealand. Haig S. Bagerdjian, Chairman and Chief Executive Officer of GMS notes: “This transaction further expands GMS's geographical presence in Australia and extends our breath of services and products in that country. Moreover, the transaction adds valued local market expertise to GMS's existing service offering. Expanding our geographical reach in Australia is an important step for GMS. It strengthens our position as an Australian nation-wide partner with the medical imaging community by adding to our ability to service clients on a local level. We look forward to continuing our long running relationship with Lantheus through our newly solidified commercial arrangement, which we believe will help both companies reach their short and long-term goals.”
Global Medical Solutions
Global Medical Solutions, Ltd. is a leading-edge provider of nuclear medicine and diagnostic imaging products and services. Global Medical Solutions operates in Australia, China, Hong Kong, New Zealand, Philippines, Taiwan, and Thailand. GMS-owned sites include radiopharmacies, drug distribution centers, cold kit manufacturing plants, brachytherapy centers, a PET cyclotron, and a radioisotope manufacturing center.
GMS Subsidiaries and Affiliates Websites
Global Medical Solutions is a proud supporter of the Society of Nuclear Medicine.